Altshuler Shaham’s Edwards Lifesciences EW Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q3
– Sell
-16,541
Closed -$1.53M – 336
2024
Q2
$1.53M Buy
16,541
+8,286
+100% +$734K 0.05% 38
2024
Q1
$789K Sell
8,255
-10,386
-56% -$872K 0.03% 46
2023
Q4
$1.42M Buy
18,641
+7,886
+73% +$549K 0.08% 29
2023
Q3
$745K Buy
10,755
+10,422
+3,130% +$838K 0.02% 54
2023
Q2
$31.4K Buy
+333
New +$28.9K ﹤0.01% 220
2022
Q3
– Sell
-301
Closed -$29K – 487
2022
Q2
$29K Sell
301
-498
-62% -$51.6K ﹤0.01% 322
2022
Q1
$94K Sell
799
-276
-26% -$31K ﹤0.01% 271
2021
Q4
$139K Buy
1,075
+5
+0.5% +$583 ﹤0.01% 293
2021
Q3
$122K Sell
1,070
-68
-6% -$7.76K ﹤0.01% 297
2021
Q2
$118K Buy
+1,138
New +$107K ﹤0.01% 297
2021
Q1
– Sell
-423
Closed -$39K – 485
2020
Q4
$39K Buy
423
+116
+38% +$9.62K ﹤0.01% 304
2020
Q3
$25K Buy
+307
New +$24K ﹤0.01% 307
2020
Q2
– Sell
-210
Closed -$14K – 427
2020
Q1
$14K Sell
210
-5,856
-97% -$422K ﹤0.01% 258
2019
Q4
$472K Buy
6,066
+5,583
+1,156% +$436K 0.01% 107
2019
Q3
$35K Buy
483
+306
+173% +$21.5K ﹤0.01% 189
2019
Q2
$11K Sell
177
-150
-46% -$9.07K ﹤0.01% 277
2019
Q1
$21K Buy
327
+177
+118% +$10.1K ﹤0.01% 172
2018
Q4
$8K Buy
+150
New +$7.59K ﹤0.01% 192

Other funds holding EW

Altshuler Shaham's EW Position: Q3 2024 in Review

Altshuler Shaham sold out of Edwards Lifesciences (EW) in Q3 2024, closing a stake of 16,541 shares — an estimated $1.53M sold.

Altshuler Shaham first reported a position in EW in Q4 2018 and held it in 18 quarters. The position peaked at $1.53M in Q2 2024. 1,195 funds tracked by Wall St. Rank hold EW as of Q3 2024.

  • Altshuler Shaham reported no remaining Edwards Lifesciences position as of Q3 2024 after selling out during the quarter.
  • Altshuler Shaham sold 16,541 Edwards Lifesciences shares in Q3 2024, an estimated $1.53M.
  • Altshuler Shaham first reported a position in Edwards Lifesciences in Q4 2018 and held it in 18 quarters.
  • Altshuler Shaham's Edwards Lifesciences position peaked at $1.53M in Q2 2024.
  • 1,195 funds tracked by Wall St. Rank held Edwards Lifesciences as of Q3 2024.

Based on Altshuler Shaham's 13F filing for Q3 2024, filed 14 Nov 2024.